Tvardi Therapeutics, Inc.
TVRDTvardi Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7.1 million, down 66.0% from fiscal 2023.
- Revenue
- +20.3%
- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
After hours trading: 0.97, down 2.02%, last trade Fri 7:28pm Eastern.
Follow TVRD
Alert me
Where the cash went Q3 FY2026, quarter to Sep 30, 2026
Free cash flow was −$6.4M: capital expenditures were more than operating cash flow. Cash rose by $6.5M. Lines the picture does not name came to +$12.9M. What is a cash flow statement?
- Free cash flow
- −$6.4M
- Returned to shareholders
- $0.00
- Debt, net
- $0.00 borrowed
- Change in cash
- +$6.5M over the period
| Operating cash flow | −6.4 |
|---|---|
| Free cash flow | −6.4 |
| Other | +12.9 |
| Change in cash | 6.5 |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Net Income |
+8 more quarters Free account |
(7.27) | (6.80) | (6.46) | (6.12) |
Depreciation & Amortization |
(0.18) | 0.02 | 0.02 | 0.02 | |
Non Cash Items (Other) |
0.54 | 0.36 | 0.34 | 0.41 | |
Change in payables and accrued liability |
0.00 | 0.21 | (2.15) | (1.11) | |
Change in other assets and liabilities |
1.23 | 0.35 | (0.99) | 0.42 | |
Operating Cash Flow |
(5.68) | (5.86) | (9.23) | (6.38) | |
Short Term Investments Change (Net) |
5.00 | 4.98 | 5.14 | 0.00 | |
Investing cash flow |
5.00 | 4.98 | 5.14 | 0.00 | |
Equity Repurchase (Common, Net) |
0.00 | — | — | — | |
Other financial activities |
0.00 | — | — | — | |
Financing cash flow |
0.00 | — | — | — | |
Change in Cash |
(0.68) | (0.88) | (4.09) | 6.51 | |
Beginning Cash |
0.00 | 20.73 | 0.00 | 0.00 | |
Ending Cash |
(0.68) | 19.85 | (4.09) | 6.51 | |
Stock Based Compensation |
0.35 | 0.37 | 0.34 | 0.39 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
1.23 | 0.57 | (3.13) | (0.69) | |
Investments Change (Net) |
5.00 | 4.98 | 5.14 | 0.00 | |
Issuance/Purchase of Shares |
0.00 | — | — | — |